Vanessa L Beesley1, Leesa F Wockner2, Peter O'Rourke2, Monika Janda3, David Goldstein4,5, Helen Gooden6, Neil D Merrett7,8, Dianne L O'Connell9, Ingrid J Rowlands10, David K Wyld11,12, Rachel E Neale2. 1. Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Vanessa.Beesley@qimrberghofer.edu.au. 2. Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia. 3. School of Public Health and Social Work, Queensland University of Technology, Brisbane, Australia. 4. Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia. 5. University of New South Wales, Sydney, Australia. 6. Cancer Nursing Research Unit, University of Sydney, Sydney, Australia. 7. Discipline of Surgery, Western Sydney University, Sydney, Australia. 8. South Western Sydney Upper GI Surgical Unit, Bankstown Hospital, Sydney, Australia. 9. Cancer Research Division, Cancer Council New South Wales, Sydney, Australia. 10. School of Public Health, The University of Queensland, Brisbane, Australia. 11. Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia. 12. University of Queensland, Brisbane, Australia.
Abstract
PURPOSE: This study aims to determine if the supportive care needs of people with pancreatic cancer change over time and identify the factors associated with current and future unmet needs. METHODS: Australian pancreatic cancer patients completed a self-administered survey at 0-6 months post-diagnosis (n = 116) then follow-up surveys 2 (n = 82) and 4 months (n = 50) later. The validated survey measured 34 needs across five domains. Weighted generalised estimating equations were used to identify factors associated with having ≥1 current or future moderate-to-high unmet need. RESULTS: The overall proportion of patients reporting ≥1 moderate-or-high-level need did not significantly change over time (baseline = 70 % to 4 months = 75 %), although there was a non-significant reduction in needs for patients who had a complete resection (71 to 63 %) and an increase in patients with locally advanced (73 to 85 %) or metastatic (66 to 88 %) disease. Higher levels of pain (OR 6.1, CI 2.4-15.3), anxiety (OR 3.3, CI 1.5-7.3) and depression (OR 3.2, CI 1.7-6.0) were significantly associated with current needs. People with pain (OR 4.9, CI 1.5-15.4), metastatic disease (OR 2.7, CI 0.7-10.0) or anxiety (OR 2.5, CI 0.7-8.6) had substantially higher odds of reporting needs at their next survey. The prevalence of needs was highest in the physical/daily living and psychological domains (both 53 % at baseline). Pain and anxiety had respectively the strongest associations with these domains. CONCLUSIONS: Careful and continued attention to pain control and psychological morbidity is paramount in addressing significant unmet needs, particularly for people with metastatic disease. Research on how best to coordinate this is crucial.
PURPOSE: This study aims to determine if the supportive care needs of people with pancreatic cancer change over time and identify the factors associated with current and future unmet needs. METHODS: Australian pancreatic cancerpatients completed a self-administered survey at 0-6 months post-diagnosis (n = 116) then follow-up surveys 2 (n = 82) and 4 months (n = 50) later. The validated survey measured 34 needs across five domains. Weighted generalised estimating equations were used to identify factors associated with having ≥1 current or future moderate-to-high unmet need. RESULTS: The overall proportion of patients reporting ≥1 moderate-or-high-level need did not significantly change over time (baseline = 70 % to 4 months = 75 %), although there was a non-significant reduction in needs for patients who had a complete resection (71 to 63 %) and an increase in patients with locally advanced (73 to 85 %) or metastatic (66 to 88 %) disease. Higher levels of pain (OR 6.1, CI 2.4-15.3), anxiety (OR 3.3, CI 1.5-7.3) and depression (OR 3.2, CI 1.7-6.0) were significantly associated with current needs. People with pain (OR 4.9, CI 1.5-15.4), metastatic disease (OR 2.7, CI 0.7-10.0) or anxiety (OR 2.5, CI 0.7-8.6) had substantially higher odds of reporting needs at their next survey. The prevalence of needs was highest in the physical/daily living and psychological domains (both 53 % at baseline). Pain and anxiety had respectively the strongest associations with these domains. CONCLUSIONS: Careful and continued attention to pain control and psychological morbidity is paramount in addressing significant unmet needs, particularly for people with metastatic disease. Research on how best to coordinate this is crucial.
Authors: Vanessa L Beesley; Melanie A Price; Penelope M Webb; Peter O'Rourke; Louise Marquart; Phyllis N Butow Journal: Psychooncology Date: 2012-08-31 Impact factor: 3.894
Authors: Vanessa L Beesley; Monika Janda; David Goldstein; Helen Gooden; Neil D Merrett; Dianne L O'Connell; Ingrid J Rowlands; David Wyld; Rachel E Neale Journal: Psychooncology Date: 2015-06-29 Impact factor: 3.894
Authors: Elizabeth A Burmeister; Dianne L OʼConnell; Vanessa L Beesley; David Goldstein; Helen M Gooden; Monika Janda; Susan J Jordan; Neil D Merrett; Madeleine E Payne; David Wyld; Rachel E Neale Journal: Pancreas Date: 2015-11 Impact factor: 3.327
Authors: Stefano Crippa; Ismael Domínguez; J Ruben Rodríguez; Oswaldo Razo; Sarah P Thayer; David P Ryan; Andrew L Warshaw; Carlos Fernández-del Castillo Journal: J Gastrointest Surg Date: 2008-03-04 Impact factor: 3.452
Authors: Shan S Wong; Thomas J George; Melyssa Godfrey; Jennifer Le; Deidre B Pereira Journal: Support Care Cancer Date: 2018-06-29 Impact factor: 3.603
Authors: Yan Jie; Ying Wang; Jingyi Chen; Chunfeng Wang; Yingchun Lin; Rong Hu; Yong Wu Journal: Health Qual Life Outcomes Date: 2020-06-23 Impact factor: 3.186
Authors: Galia Jacobson; Ronen Fluss; Amira Dany-BenShushan; Talia Golan; Tikva Meron; Camilla Zimmermann; Laura A Dawson; Aisling Barry; Marcin Miszczyk; Michael Buckstein; Dayssy Diaz Pardo; Artur Aguiar; Liat Hammer; Adam P Dicker; Maoz Ben-Ailan; Ofir Morag; David Hausner; Zvi Symon; Yaacov R Lawrence Journal: BMJ Open Date: 2022-03-24 Impact factor: 2.692